The compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein: X is selected from the group consisting of: (a) CH, and (b) N; Y is selected from the group consisting of: (a) CH, and (b) N; ring A is selected from the group consisting of: (a) cycloalkyl, (b) cycloalkenyl, (c) aryl, (d) heterocyclyl, (e) heterocyclenyl, and (f) heteroaryl, wherein said cycloalkyl, cycloalkenyl, aryl, heterocyclyl, heterocyclenyl, and heteroaryl is unsubstituted or substituted by at least one R 2, wherein when each of said cycloalkyl, cycloalkenyl, aryl, heterocyclyl, heterocyclenyl, and heteroaryl, has substituents on adjacent carbon atoms, said substituents can optionally be taken together with the carbon atoms to which they are attached to form a five- or six-membered cycloalkyl, cycloalkenyl, heterocyclyl, heterocyclenyl, aryl or heteroaryl, wherein said five- or six-membered cycloalkyl, cycloalkenyl, heterocyclyl, aryl or heteroaryl is unsubstituted or substituted by at least one R 2; each R 1 is independently selected from the group consisting of: (a) halo, (b) alkyl, (c) alkoxyl, (d) -CN, (e) -NH 2, (f) -N(alkyl) 2, (g) -N alkyl, and (h) haloalkyl; each R 2 is independently selected from the group consisting of: (a) alkyl, (b) alkoxyl, (c) haloalkyl, (d) alkenyl, (e) alkynyl, (f) -NH 2, (g) -N(alkyl) 2, (h) -N alkyl, (i) halogen, (j) -CN, (k) -OH, and (l) heterocyclyl; R 3 is selected from the group consisting of: (a) haloalkyl, (b) alkoxyl, (c) -NH 2, (d) -NH(alkyl), (e) -N(alkyl) 2, (f) aryl, (g) heteroaryl, and (h) heteroaryl-N-oxide, wherein each of said aryl, heteroaryl, or heteroaryl-N-oxide is independently unsubstituted or substituted with one or more substituents independently selected from the group consisting of alkyl, haloalkyl, alkoxyl, thioalkoxyl, NO 2, halo and -CN; R 4a and R 4b are independently selected from the group consisting of: (a) hydrogen, (b) alkyl, and (c) haloalkyl; R 5a, R 5b, R 6a, R 6b, R 7a, R 7b, R 8a and R 8b are independently selected from the group consisting of: (a) hydrogen, (b) alkyl, and (c) haloalkyl; R 9 is selected from the group consisting of: (a) hydrogen, (b) alkyl, and (c) haloalkyl; mis 1, 2, 3 or 4 and n is 0, 1, 2, 3 or 4, with the proviso that when Y is N, and Ring A is aryl, R 3 is not X is selected from the group consisting of: (a) CH, and (b) N; (a) CH, and (b) N; Y is selected from the group consisting of: (a) CH, and (b) N; (a) CH, and (b) N; ring A is selected from the group consisting of: (a) cycloalkyl, (b) cycloalkenyl, (c) aryl, (d) heterocyclyl, (e) heterocyclenyl, and (f) heteroaryl, wherein said cycloalkyl, cycloalkenyl, aryl, heterocyclyl, heterocyclenyl, and heteroaryl is unsubstituted or substituted by at least one R 2, wherein when each of said cycloalkyl, cycloalkenyl, aryl, heterocyclyl, heterocyclenyl, and heteroaryl, has substituents on adjacent carbon atoms, said substituents can optionally be taken together with the carbon atoms to which they are attached to form a five- or six-membered cycloalkyl, cycloalkenyl, heterocyclyl, heterocyclenyl, aryl or heteroaryl, wherein said five- or six-membered cycloalkyl, cycloalkenyl, heterocyclyl, aryl or heteroaryl is unsubstituted or substituted by at least one R 2; (a) cycloalkyl, (b) cycloalkenyl, (c) aryl, (d) heterocyclyl, (e) heterocyclenyl, and (f) heteroaryl, each R 1 is independently selected from the group consisting of: (a) halo, (b) alkyl, (c) alkoxyl, (d) -CN, (e) -NH 2, (f) -N(alkyl) 2, (g) -N alkyl, and (h) haloalkyl; (a) halo, (b) alkyl, (c) alkoxyl, (d) -CN, (e) -NH 2, (f) -N(alkyl) 2, (g) -N alkyl, and (h) haloalkyl; each R 2 is independently selected from the group consisting of: (a) alkyl, (b) alkoxyl, (c) haloalkyl, (d) alkenyl, (e) alkynyl, (f) -NH 2, (g) -N(alkyl) 2, (h) -N alkyl, (i) halogen, (j) -CN, (k) -OH, and (l) heterocyclyl; (a) alkyl, (b) alkoxyl, (c) haloalkyl, (d) alkenyl, (e) alkynyl, (f) -NH 2, (g) -N(alkyl) 2, (h) -N alkyl, (i) halogen, (j) -CN, (k) -OH, and (l) heterocyclyl; R 3 is selected from the group consisting of: (a) haloalkyl, (b) alkoxyl, (c) -NH 2, (d) -NH(alkyl), (e) -N(alkyl) 2, (f) aryl, (g) heteroaryl, and (h) heteroaryl-N-oxide, wherein each of said aryl, heteroaryl, or heteroaryl-N-oxide is independently unsubstituted or substituted with one or more substituents independently selected from the group consisting of alkyl, haloalkyl, alkoxyl, thioalkoxyl, NO 2, halo and -CN; (a) haloalkyl, (b) alkoxyl, (c) -NH 2, (d) -NH(alkyl), (e) -N(alkyl) 2, (f) aryl, (g) heteroaryl, and (h) heteroaryl-N-oxide, wherein each of said aryl, heteroaryl, or heteroaryl-N-oxide is independently unsubstituted or substituted with one or more substituents independently selected from the group consisting of alkyl, haloalkyl, alkoxyl, thioalkoxyl, NO 2, halo and -CN; R 4a and R 4b are independently selected from the group consisting of: (a) hydrogen, (b) alkyl, and (c) haloalkyl; (a) hydrogen, (b) alkyl, and (c) haloalkyl; R 5a, R 5b, R 6a, R 6b, R 7a, R 7b, R 8a and R 8b are independently selected from the group consisting of: (a) hydrogen, (b) alkyl, and (c) haloalkyl; (a) hydrogen, (b) alkyl, and (c) haloalkyl; R 9 is selected from the group consisting of: (a) hydrogen, (b) alkyl, and (c) haloalkyl; (a) hydrogen, (b) alkyl, and (c) haloalkyl; mis 1, 2, 3 or 4 and n is 0, 1, 2, 3 or 4, with the proviso that when Y is N, and Ring A is aryl, R 3 is not